PLN 7.45
(-0.67%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.51 Million PLN | -68.27% |
2022 | 4.77 Million PLN | -44.5% |
2021 | 8.59 Million PLN | 118.03% |
2020 | 3.94 Million PLN | 14.06% |
2019 | 3.45 Million PLN | -25.43% |
2018 | 4.63 Million PLN | 183.09% |
2017 | 1.63 Million PLN | 25.54% |
2016 | 1.3 Million PLN | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 1.58 Million PLN | 239.55% |
2024 Q1 | 1.3 Million PLN | -14.0% |
2023 Q3 | 5.36 Million PLN | 7.91% |
2023 Q4 | 1.51 Million PLN | -71.77% |
2023 FY | 1.51 Million PLN | -68.27% |
2023 Q1 | 4.14 Million PLN | -13.12% |
2023 Q2 | 4.97 Million PLN | 19.93% |
2022 Q3 | 4.55 Million PLN | 8.1% |
2022 Q2 | 4.21 Million PLN | -12.36% |
2022 Q4 | 4.77 Million PLN | 4.79% |
2022 Q1 | 4.8 Million PLN | -44.1% |
2022 FY | 4.77 Million PLN | -44.5% |
2021 FY | 8.59 Million PLN | 118.03% |
2021 Q3 | 3.65 Million PLN | -35.41% |
2021 Q4 | 8.59 Million PLN | 135.08% |
2021 Q1 | 4.43 Million PLN | 12.55% |
2021 Q2 | 5.66 Million PLN | 27.58% |
2020 Q4 | 3.94 Million PLN | 44.54% |
2020 FY | 3.94 Million PLN | 14.06% |
2020 Q3 | 2.72 Million PLN | -11.51% |
2020 Q2 | 3.08 Million PLN | 40.46% |
2020 Q1 | 2.19 Million PLN | -36.51% |
2019 Q3 | 2.43 Million PLN | -9.97% |
2019 Q2 | 2.7 Million PLN | 57.29% |
2019 Q1 | 1.71 Million PLN | -62.96% |
2019 FY | 3.45 Million PLN | -25.43% |
2019 Q4 | 3.45 Million PLN | 42.15% |
2018 Q1 | - PLN | -100.0% |
2018 Q2 | 1.46 Million PLN | 0.0% |
2018 Q3 | 4.14 Million PLN | 183.64% |
2018 FY | 4.63 Million PLN | 183.09% |
2018 Q4 | 4.63 Million PLN | 11.79% |
2017 FY | 1.63 Million PLN | 25.54% |
2017 Q4 | 1.63 Million PLN | 0.0% |
2016 FY | 1.3 Million PLN | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Adiuvo Investments S.A. | 45.77 Million PLN | 96.693% |
Genomtec S.A. | 4.45 Million PLN | 65.978% |
Medicalgorithmics S.A. | 29.06 Million PLN | 94.791% |
Synektik Spólka Akcyjna | 146.03 Million PLN | 98.963% |